Science Current Events | Science News | Brightsurf.com
 

Large global range of prices for hepatitis C medicines raises concerns about affordability

June 01, 2016

The prices and affordability of recently developed and highly effective direct-acting antivirals for treating hepatitis C (HCV) vary greatly among countries worldwide, according to a study published this week in PLOS Medicine. Suzanne Hill and colleagues from the World Health Organization undertook an economic analysis of prices for a 12-week course of treatment with sofosbuvir and ledipasvir/sofosbuvir in 30 countries - mostly European as well as Egypt and Mongolia, adjusting for average 2015 exchange rates and purchasing power parity (PPP). While the nominal price based on exchange rates was highest in the US (US$72,765 for a 12-week course of ledipasvir/sofosbuvir), PPP-adjusted prices in Central and Eastern European countries were highest, costing up to 1.63 times as much in Poland (PPP$118,754 for a 12 week course of ledipasvir/sofosbuvir). The researchers went on to calculate the cost of treating the entire HCV infected population in each of the countries studied. Using previous estimates of HCV burden by country, they calculated that it would range from 10.5% of the total pharmaceutical expenditure (TPE) to treat all HCV patients in the Netherlands with the new HCV medications, to 190.5% of the TPE to treat all patients in Poland.

The authors note that their analysis is limited by the accuracy of the estimates of the numbers of people infected and price information that was accessible, and that some actual prices may be lower than the publicly accessible numbers because of confidential discounts. They also note, however, that they only considered the cost of sofosbuvir and ledipasvir/sofosbuvir and did not consider extra costs of treatment such as screening and follow-up. The authors say their analysis illustrates the wide range of affordability worldwide and suggests a need for an updated pricing system: "In order for countries to increase investment and minimise the burden of hepatitis C, governments and industry stakeholders will need to jointly develop and implement fairer pricing frameworks that deliver lower and more affordable prices".

In an accompanying Perspective, Elliot Marseille and James G. Kahn discuss the pricing of these new HCV medications in relation to the high initial cost when HIV anti-retroviral therapy was introduced in the 1990s. Marseille and Kahn compare and contrast the situations, and suggest ways forward such as treating a proportion of cases initially, to spread the upfront cost of HCV treatment over several years while fighting for lower drug prices.

###

Research Article

Funding:

The authors received no specific funding for this work.

Competing Interests:

SH is a member of the PLOS Medicine Editorial Board. KTT has been an employee of Deloitte Australia within the past 5 years. Deloitte Australia has provided consulting services to pharmaceutical companies. However, KTT has not been involved in any project directly related to the content of this manuscript that can lead to conflict of interest.

Citation:

Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, et al. (2016) Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis. PLoS Med 13(5): e1002032. doi:10.1371/journal.pmed.1002032

Author Affiliations:

World Health Organization, Geneva, Switzerland

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Health Economics Department, Gesundheit Ă-sterreich, Vienna, Austria

PLOS


Related Hepatitis Current Events and Hepatitis News Articles


Autism care improved, diagnosis time shortened by new MU program
Wait lists for a specialist to confirm an autism diagnosis can be agonizing and last months. As the prevalence of autism and autism spectrum disorders increase, so does the demand for a health care system that is fully equipped to respond to the complex needs associated with autism.

Study reveals protein that dials immune responses up and down
Research led by scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) has identified a new regulator of immune responses.

Could hepatitis C treatments help prevent virus transmission?
An international team of researchers has shed light on the potential impact of new drugs for hepatitis C virus (HCV).

Experimental drug against hepatitis C slows down Zika virus infection in mice
Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy.

New study finds asthma patients rely heavily on rescue inhalers, difficult to diagnose
In a new national survey of asthma patients, Health Union, and its new online community Asthma.net, reveals that most were satisfied with the care they received; however, the most frequently used form of treatment, at 89%, is the rescue inhaler.

Alcohol accelerates liver damage in people living with hepatitis C
Drinking alcohol can increase the risk of illness and death from the hepatitis C virus. A new national household study of U.S. adults published in the American Journal of Preventive Medicine shows that many people living with hepatitis C report either former or current excessive alcohol use.

Immunization rates climb when pediatricians have easy access to vaccination records
Exchange of immunization data between a centralized city immunization registry and provider electronic health records led to significant improvements in pediatric immunization coverage, a reduction in over-immunization for adolescents, and increased completeness of immunization records.

Studies demonstrate improved safety results achieved with investigational drug for hep B
Studies presented today at The International Liver Congress™ 2016 in Barcelona, Spain, demonstrate that tenofovir alafenamide (TAF) improves patient safety while maintaining efficacy in patients with chronic Hepatitis B virus (HBV) infection compared to tenofovir disoproxil fumarate (Viread, TDF).

New treatment algorithm can predict benefit of treatment in end-stage liver disease
A new algorithm designed to help physician decision-making in End-Stage Liver Disease (ESLD), was able to accurately predict death in 96% of patients with ESLD.

Study demonstrates benefits of existing treatment for hepatitis D patients
New research presented today shows that interferon alpha (IFNa) based therapies are effective in suppressing disease progression in a severe form of chronic viral hepatitis, Hepatitis delta.
More Hepatitis Current Events and Hepatitis News Articles

NOFX: The Hepatitis Bathtub and Other Stories

NOFX: The Hepatitis Bathtub and Other Stories
by NOFX (Author), Jeff Alulis (Author)


NOFX: The Hepatitis Bathtub and Other Stories is the first tell-all autobiography from one of the world's most influential and controversial punk bands. Fans and non-fans alike will be shocked by the stories of murder, suicide, addiction, counterfeiting, riots, bondage, terminal illness, the Yakuza, and drinking pee. Told from the perspective of each of the band's members, this book looks back at more than thirty years of comedy, tragedy, and completely inexplicable success.


Hepatitis C: A Complete Guide for Patients and Families (A Johns Hopkins Press Health Book)

Hepatitis C: A Complete Guide for Patients and Families (A Johns Hopkins Press Health Book)
by Paul J. Thuluvath (Author)


The liver is the body’s workhorse. It makes proteins and bile, processes fats, and detoxifies drugs and alcohol. The liver is a resilient organ, but it is susceptible to damage from a number of sources, including viral infections. Such infections cause inflammation of the liver, called hepatitis. This book is a comprehensive guide to hepatitis C, which affects about 3 percent of the world’s population―3 to 4 million people in the United States alone. Some people with acute hepatitis C infection will be cured without any treatment, but when hepatitis C becomes chronic it may cause cirrhosis, liver cancer, and death.Hepatitis C is transmitted from an infected person to an uninfected person by sharing drug-injecting equipment, snorting cocaine, having sex, or getting a blood...

HEPATITIS: A-to-E, Autoimmune, & Drug-induced: Symptoms, Transmissions, Diagnosis,  Treatments, Diet, Preventions, Research

HEPATITIS: A-to-E, Autoimmune, & Drug-induced: Symptoms, Transmissions, Diagnosis, Treatments, Diet, Preventions, Research
by James Lee Anderson (Author)


“Although, your health condition may impact your everyday life, do not let it define who you are.” Most people have heard of hepatitis, but few understand the harm posed by this potentially deadly collection of diseases. This text covers what you need to know about the disease. Inside, you’ll be able to know: (1) between acute and chronic hepatitis, (2) the different types of hepatitis, from A to E, (3) symptoms, causes and transmissions, diagnosis, treatments, and preventions, (4) about drug-induced hepatitis, (5) about autoimmune hepatitis, (6) how liver biopsy is done, (7) alternative treatments, (8) how to manage the pain in hepatitis, (9) how to manage mental health, (10) how to manage together diabetes and hepatitis, (11) what the diet and nutrition is for people with...

Hepatitis B Virus, An Issue of Clinics in Liver Disease, 1e (The Clinics: Internal Medicine)

Hepatitis B Virus, An Issue of Clinics in Liver Disease, 1e (The Clinics: Internal Medicine)
by Tarek I. Hassanein MD (Author)


HBV is most prevalent viral infection worldwide. Recent advances in HBV virology epidemiology and management are of utmost importance particularly during this time when HCV is taking the front row in discussion and research. However, there’s an increased interest in management of HBV in special populations, which is covered in this issue. The authors also explore drugs in the pipeline as well as new approaches for achieving long-term viral suppression and possibly cure.

Typical TCM Therapy for Viral Hepatitis (English-Chinese Guide to Clinical Treatment of Common Diseases) (English and Chinese Edition)

Typical TCM Therapy for Viral Hepatitis (English-Chinese Guide to Clinical Treatment of Common Diseases) (English and Chinese Edition)
by Xue Boyu (Author)


This book gives a brief description of every type of hepatitis based on the characteristics of TCM treatments for viral hepatitis, including internal therapy, external therapy, acupuncture, massage, physical training and psychotherapy. The book also analyses the common manifestations and complications of the disease based on differential diagnosis in TCM.

Healing Hepatitis and Liver Disease Naturally: Detoxification. Liver gall bladder flush & Cleanse. Cure Hepatitis C and Hepatitis B. Lower blood cholesterol and stop cirrhosis

Healing Hepatitis and Liver Disease Naturally: Detoxification. Liver gall bladder flush & Cleanse. Cure Hepatitis C and Hepatitis B. Lower blood cholesterol and stop cirrhosis
by Peter Oyakhire (Author)


LIVE YOUR LIFE EXPECTANCY WITH CHRONIC LIVER DISEASE.

Studies show that all wellness traditions except western medicine offer detoxification and toxic waste management as a means of natural healing. Using the principles of natural healing and detoxification, Dr. Alexis Carrel, a Nobel Prize winner kept chicken heart alive for 38 years. He believed that cells could live indefinitely and that the secret of life is to feed nutrients to cells and to saturate the cells with Oxygen. If you can't get nutrients into the cells and you don't remove the toxins, the cells will be poisoned by their own waste products. He had found the secret to ageless body and timeless health.

Often overlooked is the pain associated with orthodox management of infective and degenerative liver diseases...

Herbs for Hepatitis C and the Liver (A Storey Medicinal Herb Guide)

Herbs for Hepatitis C and the Liver (A Storey Medicinal Herb Guide)
by Stephen Harrod Buhner (Author)


Providing practical guidance and hope, Stephen Harrod Buhner offers a thorough examination of the most effective herbal remedies for hepatitis C. While promoting a protocol of cleansing the liver and strengthening the immune system through a combination of diet, herbal medicines, and lifestyle changes, this guide will help you choose the best remedies for your individual needs. Clear descriptions of how common herbal treatments work to combat hepatitis C will empower you to make informed choices that can successfully mitigate your suffering. 

Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease: A Practical Guide to Understanding, Treating & Living with Hepatitis & Liver

Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease: A Practical Guide to Understanding, Treating & Living with Hepatitis & Liver
by Melissa Palmer (Author)


In the United States alone, more than four million people are infected with the hepatitis C virus, and chronic liver disease is the twelfth leading cause of death.

In this revised and updated edition of her groundbreaking 2000 book, renowned hepatologist Dr. Melissa Palmer discusses all facets of liver disease, from symptoms and tests to treatment options and lifestyle changes. In addition, this comprehensive handbook reveals cutting-edge research on the dangers of hepatitis C, one of the world's fasting-growing microbial threats.

The Sanford Guide to Hepatitis Therapy 2016-2017

The Sanford Guide to Hepatitis Therapy 2016-2017
by Michael S., M.D. Saag (Editor), Henry F., M.D. Chambers (Editor), George M., M.D. Eliopoulos (Editor), David N., M.D. Gilbert (Editor)




Understanding Hepatitis chart: Wall Chart

Understanding Hepatitis chart: Wall Chart
by Scientific Publishing (Author)


The Understanding Hepatitis chart is a comprehensive overview of the different types of hepatitis, including symptoms, causes and treatments. External views of healthy and cirrhotic livers are shown, including a view of the liver lobules. Heavy cover stock with protective varnish for durability.

© 2017 BrightSurf.com